Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Luobitong Tablets for Moderate-to-Severe Active Rheumatoid Arthritis
CTR20220909Phase 3Completed
- Sponsor
- Yiling Pharmaceutical
- Start
- Apr 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of luobitong in rheumatoid arthritis (RA), sponsored by Yiling Pharmaceutical. Started Apr 2022; status: completed.
02
Drugs
luobitong
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on CTR20220909.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20220909.